70 related articles for article (PubMed ID: 28713898)
21. Expression of CCL2, FOS, and JUN May Help to Distinguish Patients With IgA Nephropathy From Healthy Controls.
Zhou X; Wang N; Zhang Y; Yu P
Front Physiol; 2022; 13():840890. PubMed ID: 35464092
[TBL] [Abstract][Full Text] [Related]
22. Identification of blood-based key biomarker and immune infiltration in Immunoglobulin A nephropathy by comprehensive bioinformatics analysis and a cohort validation.
Xu J; Shen X; Wei X; Ding J; Yuan J; Weng Z; He Y
J Transl Med; 2022 Mar; 20(1):145. PubMed ID: 35351150
[TBL] [Abstract][Full Text] [Related]
23. Genome-wide analysis of long noncoding RNAs as cis-acting regulators of transcription factor-encoding genes in IgA nephropathy.
Zhai Y; Tian H; Zhang W; Sun S; Zhao Z
PLoS One; 2024; 19(5):e0304301. PubMed ID: 38787831
[TBL] [Abstract][Full Text] [Related]
24. Comprehensive Bioinformatics Analysis Identifies
You S; Xu J; Wu B; Wu S; Zhang Y; Sun Y; Zhang N
Front Genet; 2021; 12():698570. PubMed ID: 34422001
[TBL] [Abstract][Full Text] [Related]
25. The Clinical Significance and Potential Role of Cathepsin S in IgA Nephropathy.
Zhao J; Yang Y; Wu Y
Front Pediatr; 2021; 9():631473. PubMed ID: 33912521
[No Abstract] [Full Text] [Related]
26. Toll-Like Receptor as a Potential Biomarker in Renal Diseases.
Mertowski S; Lipa P; Morawska I; Niedźwiedzka-Rystwej P; Bębnowska D; Hrynkiewicz R; Grywalska E; Roliński J; Załuska W
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32933213
[TBL] [Abstract][Full Text] [Related]
27. Octreotide Delaying the Progression of Recurrent IgA Nephropathy After Kidney Transplantation.
Sharma A; Hariharan S
Transplant Direct; 2020 Jan; 6(1):e518. PubMed ID: 32047846
[TBL] [Abstract][Full Text] [Related]
28. Screening and Bioinformatics Analysis of IgA Nephropathy Gene Based on GEO Databases.
Qian W; Xiaoyi W; Zi Y
Biomed Res Int; 2019; 2019():8794013. PubMed ID: 31392215
[TBL] [Abstract][Full Text] [Related]
29. Identification of potential biomarkers and therapeutic targets for human IgA nephropathy and hypertensive nephropathy by bioinformatics analysis.
Cui Y; Liu S; Cui W; Gao D; Zhou W; Luo P
Mol Med Rep; 2017 Sep; 16(3):3087-3094. PubMed ID: 28713898
[TBL] [Abstract][Full Text] [Related]
30. Bioinformatics analysis reveals novel hub gene pathways associated with IgA nephropathy.
Jiang X; Xu Z; Du Y; Chen H
Eur J Med Res; 2020 Sep; 25(1):40. PubMed ID: 32894197
[TBL] [Abstract][Full Text] [Related]
31. Identifying potential biomarkers for the diagnosis and treatment of IgA nephropathy based on bioinformatics analysis.
Li X; Zeng M; Liu J; Zhang S; Liu Y; Zhao Y; Wei C; Yang K; Huang Y; Zhang L; Xiao L
BMC Med Genomics; 2023 Mar; 16(1):63. PubMed ID: 36978098
[TBL] [Abstract][Full Text] [Related]
32. Comprehensive analysis of IgA nephropathy expression profiles: identification of potential biomarkers and therapeutic agents.
Gholaminejad A; Gheisari Y; Jalali S; Roointan A
BMC Nephrol; 2021 Apr; 22(1):137. PubMed ID: 33874912
[TBL] [Abstract][Full Text] [Related]
33. Identification and validation of glomerulotubular crosstalk genes mediating IgA nephropathy by integrated bioinformatics.
Bai Y; Li Y; Xi Y; Ma C
BMC Nephrol; 2022 Apr; 23(1):143. PubMed ID: 35418061
[TBL] [Abstract][Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
